Omeros
is a Wasington-based biopharmaceutical company that researches and develops small-molecule and protein therapeutics for the treatment of inflammation and CNS disorders... Read moreOmeros
is a Wasington-based biopharmaceutical company that researches and develops small-molecule and protein therapeutics for the treatment of inflammation and CNS disorders... Read more
News
Apr 11, 2025
Benzinga
Omeros: Omeros' New Leukemia Drug Team Ignites Hope For Cancer Fight
Apr 10, 2025
StreetInsider
Press Release: Omeros : Omeros Announces the Omeros Oncology Clinical Steering Committee for AML to Help Guide Omeros' Proprietary OncotoX-AML Clinical Program
Apr 01, 2025
Owler
Omeros Corp.: Omeros's employee count changed from 198 in Dec 2023 to 202 in Dec 2024
Apr 01, 2025
Seeking Alpha
Omeros: Omeros Corporation (OMER) Q4 2024 Earnings Call Transcript
Mar 31, 2025
Marketscreener
Omeros: Omeros Corporation Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2024
Mar 24, 2025
Clinical Trials Arena
Omeros: Omeros to activate site for Phase III programme of zaltenibart for PNH
Mar 21, 2025
centralcharts
Press Release: Omeros : Omeros Corporation Provides Update of Ongoing Zaltenibart Phase 3 PNH Clinical Trial Program
Mar 13, 2025
Business Wire
Press Release: Omeros : Omeros Corporation Receives Commitment of Over $4 Million from NIDA for Further Development of the Company's OMS527 Program to Treat Cocaine Use Disorder
Feb 24, 2025
Seeking Alpha
Omeros: Omeros Corporation: Scientifically Compelling Again, But The Delay Has Cost Us
Feb 20, 2025
centralcharts
Press Release: Omeros : Omeros Announces Robust Results for Narsoplimab Expanded Access Program in TA-TMA
Omeros Competitors
1
2
3
4
5
6
7
8
9
10